Physicians' Academy for Cardiovascular Education

How will outcomes of ARNI trials impact diagnosis and management of HF?

10' education - Aug. 26, 2020 - Prof. Mark Petrie, MD - University of Glasgow, UK

Video navigation menu

  • First case presentation of a HFpEF patient 02:22
  • PARAGON-HF trial: design and outcomes 03:36
  • Summary of end points in PARAGON-HF, and interpretations of results 8:06
  • Second case presentation of a HFrEF patient 10:30
  • Outcomes of HF trials 11:40
  • Guideline recommendations 15:00
  • Ongoing HF trials 16:09

Educational information

This video by prof. Mark Petrie, MD is part of the 3rd Groningen Heart Failure symposium "How to implement the newest heart failiure therapies? - A case-based approach".


Prof. Mark Petrie, MD is professor at the Institute of Cardiovascular & Medical Sciences at the University of Glasgow, UK.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Multisponsored funding for this educational program was provided by AstraZeneca, Pfizer, Vifor and Novartis.

Click here for the introduction of this symposium

Share this page with your colleagues and friends: